Isofol Medical AB (publ)

kr 1.41As of Sun 8 Nov 2026, 12:00 UTC
STO:ISOFOLHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (20.89%)
Div yield —
ROE (78.31%)
Biotechnology
Beta (5Y) 1.29
PE TTM —
TSR TTM 104.93%
Mkt cap kr 453.2M
ROIC (50.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.52
7.55%
(6.19%)
Hold 0|11|9|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.02
0.02
0.03
0.03
25.20%
29.13%
24.39%
24.70%
Revenuekr M
35.22
36.52
38.16
37.58
9.55%
15.79%
15.10%
13.00%
Peers (US$45.82M)
Cap (US$)
PE
45.75M
2.402x
Capital
TTM
5Y
10Y
Leveragex
0.242
—
—
EBIT/Intx
0.740
0.302
0.286
Own earn%
(28.36)
21.54
23.66
Sh yield%
52.75
37.43
37.81
Owners
Insiders/Inst%
3.20
83.26
Short interest%
2.02
SBC / revenue%
5.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
16–25
$1 testx
—
Incr. ROIC%
46